FDA cleared the Omnifit® 20° Series I Insert;Omnifit® Crossfire® 10° Series II Insert; Constrained Acetabular Insert; Trident® Crossfire® 0° Polyethylene Insert; Trident ® Crossfire ® 10° Polyethylene Insert;System 12 Crossfire® 10° Insert; Trident® 0° Constrained Acetabular Insert; Trident® Constrained Acetabular Liner;Trident® All Poly Constrained Acetabular Insert; Crossfire® Eccentric Insert 10°; Artisan® Bone Plug;UHR® Universal Head Bipolar Component from Howmedica Osteonics Corp., Dba Stryker Orthopaedics on Jul 10, 2026 under K261624, a traditional 510(k). The device falls under product code LPH, Prosthesis, Hip, Semi-Constrained, Metal/Polymer, Porous Uncemented, regulated at 21 CFR 888.3358 as a Class 2 device. The review panel was Orthopedic.

FDA logged the submission as received on May 15, 2026. The decision came 56 days later, inside the 90 FDA-day goal for a 510(k).

Howmedica Osteonics Corp., Dba Stryker Orthopaedics has 4 other decisions in the tracker over the last 12 months: K261898 (Triathlon® Knee System; Triathlon® Hinge Knee System; Scorpio® Total Knee System), K253637 (Triathlon® Total Knee System - Triathlon® X3® Medial Stabilized Tibial Bearing Insert), K252898 (Triathlon® Tritanium® Asymmetric Patella; Triathlon® Tritanium® Symmetric Patella; Triathlon® Symmetric Patella; Triathlon® Asymmetric Patella; Scorpio® Universal Dome Patella; Triathlon® Hinge Bumper), K252044 (Triathlon® Total Knee System - Triathlon® Gold Femoral Components).